Claudia C Dos Santos1. 1. Interdepartmental Division of Critical Care, University of Toronto, 30, Bond Street 4-008, M5G 1W8, Toronto, Ontario, Canada. Claudia.santos@utoronto.ca
Abstract
BACKGROUND: Acute respiratory distress syndrome (ARDS) is the most severe manifestation of acute lung injury (ALI). In patients who survive the acute injury the process of repair and remodelling may be an independent risk factor determining morbidity and mortality. This review explores recent advances in the field of fibroproliferative ARDS/ALI, with a special emphasis on (a) the primary contributing factors with a focus on cellular and soluble factors, and (b) mechanisms involved in repair and remodelling as they pertain to the importance of cell death, re-population, and matrix deposition. DISCUSSION: Factors influencing progression to fibroproliferative ARDS vs. resolution and reconstitution of the normal pulmonary parenchymal architecture are poorly understood. Determinants of persistent injury and abnormal repair and remodelling may be profoundly affected by both environmental and genetic factors. Moreover, cumulative evidence suggests that acute inflammation and fibrosis may be in part independent and interactive processes that are autonomously regulated and thus amenable to individual and specific therapy. CONCLUSIONS: Although our current understanding of these processes is limited by the inability to accurately replicate the complex human physiology in laboratory settings, it has recently become apparent that the process of repair and remodelling begins early in the course of ARDS/ALI and may be determined by the type of pulmonary injury. Understanding the mechanisms leading to and regulating fibroproliferative changes may contribute to the development of novel early therapeutic interventions in ARDS/ALI patients.
BACKGROUND: Acute respiratory distress syndrome (ARDS) is the most severe manifestation of acute lung injury (ALI). In patients who survive the acute injury the process of repair and remodelling may be an independent risk factor determining morbidity and mortality. This review explores recent advances in the field of fibroproliferative ARDS/ALI, with a special emphasis on (a) the primary contributing factors with a focus on cellular and soluble factors, and (b) mechanisms involved in repair and remodelling as they pertain to the importance of cell death, re-population, and matrix deposition. DISCUSSION: Factors influencing progression to fibroproliferative ARDS vs. resolution and reconstitution of the normal pulmonary parenchymal architecture are poorly understood. Determinants of persistent injury and abnormal repair and remodelling may be profoundly affected by both environmental and genetic factors. Moreover, cumulative evidence suggests that acute inflammation and fibrosis may be in part independent and interactive processes that are autonomously regulated and thus amenable to individual and specific therapy. CONCLUSIONS: Although our current understanding of these processes is limited by the inability to accurately replicate the complex human physiology in laboratory settings, it has recently become apparent that the process of repair and remodelling begins early in the course of ARDS/ALI and may be determined by the type of pulmonary injury. Understanding the mechanisms leading to and regulating fibroproliferative changes may contribute to the development of novel early therapeutic interventions in ARDS/ALI patients.
Authors: Shastri Sookhai; Jiang Juai Wang; Morgan McCourt; William Kirwan; David Bouchier-Hayes; Paul Redmond Journal: Ann Surg Date: 2002-02 Impact factor: 12.969
Authors: M C Tamby; Y Chanseaud; M Humbert; J Fermanian; P Guilpain; P Garcia-de-la-Peña-Lefebvre; S Brunet; A Servettaz; B Weill; G Simonneau; L Guillevin; M C Boissier; L Mouthon Journal: Thorax Date: 2005-09 Impact factor: 9.139
Authors: Mauricio Rojas; Jianguo Xu; Charles R Woods; Ana L Mora; Willy Spears; Jesse Roman; Kenneth L Brigham Journal: Am J Respir Cell Mol Biol Date: 2005-05-12 Impact factor: 6.914
Authors: Richard P Marshall; Suzanne Webb; Geoffrey J Bellingan; Hugh E Montgomery; Babar Chaudhari; Robin J McAnulty; Steve E Humphries; Mike R Hill; Geoffrey J Laurent Journal: Am J Respir Crit Care Med Date: 2002-09-01 Impact factor: 21.405
Authors: Elnara M Negri; Cristiane Hoelz; Carmen S V Barbas; Gregorio Santiago Montes; Paulo H N Saldiva; Vera L Capelozzi Journal: Pathol Res Pract Date: 2002 Impact factor: 3.250
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard Journal: Intensive Care Med Date: 2007-01-13 Impact factor: 17.440
Authors: Vanessa Zambelli; Giuseppe Di Grigoli; Margherita Scanziani; Silvia Valtorta; Maria Amigoni; Sara Belloli; Cristina Messa; Antonio Pesenti; Ferruccio Fazio; Giacomo Bellani; Rosa Maria Moresco Journal: Intensive Care Med Date: 2012-01-26 Impact factor: 17.440
Authors: F R D'Alessio; J M Craig; B D Singer; D C Files; J R Mock; B T Garibaldi; J Fallica; A Tripathi; P Mandke; J H Gans; N Limjunyawong; V K Sidhaye; N M Heller; W Mitzner; L S King; N R Aggarwal Journal: Am J Physiol Lung Cell Mol Physiol Date: 2016-02-19 Impact factor: 5.464
Authors: Ellen L Burnham; William J Janssen; David W H Riches; Marc Moss; Gregory P Downey Journal: Eur Respir J Date: 2013-03-21 Impact factor: 16.671